![1]()
News
Empagliflozin a winner in challenging arena of stabilized acute HF
November 19, 2021
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.
![1]()
News
Early rhythm control in atrial fibrillation (EAST-AFNET trial)
November 17, 2021
Is rhythm control superior to rate control in treating early atrial fibrillation (AFib)?
![1]()
News
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
November 17, 2021
A landmark trial proved empagliflozin’s efficacy in HFpEF, but many patients had “moderately reduced” EFs. The findings hold up even without them.
![1]()
News
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
November 17, 2021
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.
![1]()
News
EHRs have no impact on inpatient heart failure clinical choices or outcomes
November 15, 2021
Relative to usual care, prognostic information at the bedside provided no advantage for heart failure care.
![1]()
News
Troponin elevation at any age is a risk for cardiac mortality
November 15, 2021
Is an elevated troponin value associated with increased mortality, regardless of age?
![1]()
News
BP Track: Blood pressure control rates dropped during pandemic
November 14, 2021
Data culled from 24 health systems showed lower rates of blood pressure control during the COVID-19 pandemic.
News
ASNC rejects new chest pain guideline it helped create
November 2, 2021
“We believe that the document fails to provide unbiased guidance to health care professionals on the optimal evaluation of patients with chest pain.”
![1]()
News
AHA/ACC issues first comprehensive guidance on chest pain
October 29, 2021
The clinical practice guideline offers a contemporary approach to determine which patients need further testing and which do not.
News
Fluoroquinolones linked to sudden death risk for those on hemodialysis
October 25, 2021
Most patients undergoing hemodialysis have a least one risk factor for drug-induced QT interval prolongation.
